These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 16904965

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.
    Flowers A, Chu QD, Panu L, Meschonat C, Caldito G, Lowery-Nordberg M, Li BD.
    Surgery; 2009 Aug; 146(2):220-6. PubMed ID: 19628077
    [Abstract] [Full Text] [Related]

  • 4. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer.
    Holm N, Byrnes K, Johnson L, Abreo F, Sehon K, Alley J, Meschonat C, Md QC, Li BD.
    Ann Surg Oncol; 2008 Nov; 15(11):3207-15. PubMed ID: 18719964
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma.
    Li BD, Liu L, Dawson M, De Benedetti A.
    Cancer; 1997 Jun 15; 79(12):2385-90. PubMed ID: 9191527
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
    Wang R, Geng J, Wang JH, Chu XY, Geng HC, Chen LB.
    Lung Cancer; 2009 Nov 15; 66(2):237-44. PubMed ID: 19261348
    [Abstract] [Full Text] [Related]

  • 16. Translation of the radioresistance kinase TLK1B is induced by gamma-irradiation through activation of mTOR and phosphorylation of 4E-BP1.
    Sunavala-Dossabhoy G, Fowler M, De Benedetti A.
    BMC Mol Biol; 2004 Apr 07; 5():1. PubMed ID: 15070431
    [Abstract] [Full Text] [Related]

  • 17. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke.
    Woodward WA, Giordano SH, Duan Z, Hortobagyi GN, Buchholz TA.
    Cancer; 2006 Jun 15; 106(12):2556-62. PubMed ID: 16691617
    [Abstract] [Full Text] [Related]

  • 18. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.
    Breast Cancer Res Treat; 2008 Jun 15; 109(3):405-16. PubMed ID: 17687650
    [Abstract] [Full Text] [Related]

  • 19. Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome.
    Li BD, Gruner JS, Abreo F, Johnson LW, Yu H, Nawas S, McDonald JC, DeBenedetti A.
    Ann Surg; 2002 May 15; 235(5):732-8; discussion 738-9. PubMed ID: 11981220
    [Abstract] [Full Text] [Related]

  • 20. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications.
    Nathan CO, Sanders K, Abreo FW, Nassar R, Glass J.
    Cancer Res; 2000 Jul 01; 60(13):3599-604. PubMed ID: 10910074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.